Filtern
Volltext vorhanden
- ja (7)
Gehört zur Bibliographie
- ja (7)
Dokumenttyp
Sprache
- Englisch (7)
Schlagworte
- GVHD (2)
- allogeneic stem cell transplantation (2)
- gemcitabine (2)
- 5-Fluorouracil (1)
- Alpha-dependent apoptosis (1)
- C-IAP1 (1)
- CIAP1 (1)
- Cancer (1)
- Caspase-8 activation (1)
- Complex (1)
- FOLFIRI (1)
- FOLFOX (1)
- GVL (1)
- HLA antigens (1)
- Kappa-B activation (1)
- LPS (1)
- Medizin (1)
- Necrosis (1)
- RIP1 (1)
- T cell (1)
- TRAF2 (1)
- adenocarcinoma of the ampulla of Vater (1)
- allogeneic hematopoietic stem cell transplantation (1)
- bacterial infection (1)
- folinic acid (1)
- fungi (1)
- immune reconstitution (1)
- intestinal-type adenocarcinoma (1)
- irinotecan (1)
- locally advanced disease (1)
- mismatch (1)
- nab-paclitaxel (1)
- nanoparticle albumin-bound paclitaxel (1)
- neoadjuvant chemotherapy (1)
- oxaliplatin (1)
- pancreatic cancer (1)
- pancreatobiliary type (1)
- pathogen-associated molecular patterns (1)
- virus (1)
- virus-specific T-cell (1)
Immune reconstitution of functional virus-specific T cells after allogeneic hematopoietic stem cell transplantation (HSCT) has been intensively investigated. However, the possible role of crossreactivity of these virus-specific T cells against allogeneic targets is still unclear. Theoretically, as in the field of organ transplantation, virus-specific T cells possess crossreactivity potential after allogeneic HSCT. Such crossreactivity is assumed to play a role in graft-versus-host disease and graft-versus-leukemia effects. In this article, we aim to give a comprehensive overview of current understanding about crossreactivity of virus-specific T cells.